Autres langues Edwards Lifesciences Corporation

Actions

EW

US28176E1082

Equipement et technologie médicale avancés

Marché Fermé - NYSE 22:00:02 07/10/2026			Varia. 5j.	Varia. 1 janv.
85,78 ^USD	-0,81%		-0,63%	+0,62%

05/10	Edwards Lifesciences Corporation : Evercore ISI optimiste sur le dossier	ZM
02/10	Edwards Lifesciences Corporation : JPMorgan Chase optimiste sur le dossier	ZM

Autres langues

07/10	Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
05/10	Edwards Lifesciences to Host Investor Event in Conjunction With TCT
01/10	Edwards Lifesciences Says US FDA Approves AUTUS Pediatric Pulmonary Valve
01/10	Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
01/10	Edwards Lifesciences Receives FDA Approval For AUTUS Size-Adjustable Valve
30/09	Edwards Lifesciences' TAVR Evaluation in Moderate Aortic Stenosis Among Most Awaited Clinical Trial Readouts, Oppenheimer Says
11/09	Edwards Lifesciences Reaffirms 2026 Guidance Following Medicare TAVR Decision
10/09	Edwards Lifesciences Comments on TAVR National Coverage Decision
02/09	Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit
27/08	Edwards Lifesciences Insider Sold Shares Worth $2,894,440, According to a Recent SEC Filing
25/08	Do I Really Need To File? HSR Avoidance And The Edwards/Genesis Settlement (Podcast)
17/08	Becton Dickinson Names Gary Sorsher as Chief Quality Officer
05/08	FTC Reaches $12 Million Settlement Over Alleged HSR Act Violations
05/08	Edwards Lifesciences : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
04/08	Tranche Update on Edwards Lifesciences Corporation (NYSE:EW)'s Equity Buyback Plan announced on July 28, 2022.
29/07	Edwards Lifesciences Insider Sold Shares Worth $818,958, According to a Recent SEC Filing
24/07	Edwards Lifesciences Seen Building on Catalyst Pipeline, RBC Says
24/07	Unternehmenskalender vom 27. bis 31. Juli 2026
24/07	Substance Over Form: The FTC’s $12 Million HSR Evasion Penalty And What It Signals For Dealmakers
24/07	FTC Secures $12 Million In Penalties For Alleged HSR Violation
23/07	Edwards Lifesciences beats quarterly estimates on strong demand for heart devices
23/07	Stocks to Watch : Intel, Deckers, Edwards Lifesciences, Genmab
23/07	Edwards Lifesciences Q2 Adjusted Earnings, Revenue Rise; Q3 Guidance Set
23/07	(EW) Edwards Lifesciences Corporation Expects Q3 Revenue Range $1.63B - $1.71B
23/07	(EW) Edwards Lifesciences Corporation Expects Q3 Adjusted EPS Range $0.71 - $0.77